Ju Dong Yang

58PUBLICATIONS
212CO-AUTHORS
Haematological tumoursPredictive and prognostic markersMajor global burdens of diseaseCancer geneticsToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (58)

|Jun 15, 2026
Current advances and future directions in the management of HBV-related hepatocellular carcinoma.

|Apr 27, 2026
Natural Autoantibodies Negatively Correlate with Hepatocellular Carcinoma Incidence in Cirrhosis.

|Apr 25, 2026
Updated Epidemiology of Gastrointestinal Cancers in the Asia-Pacific: Evidence From GBD 2021 and GLOBOCAN 2022.

|Apr 14, 2026
Patient Preferences in Hepatocellular Carcinoma Surveillance: A Multisite Conjoint Analysis.

Karissa D Kao, Jonathan P Troost, Ju Dong Yang

|Mar 17, 2026
Assessing Major Adverse Liver Outcomes With Baclofen Compared to Acamprosate in Compensated Alcohol-Associated Cirrhosis.

Yee Hui Yeo, Sepideh Mehravar, Ellen Choi

|Mar 07, 2026
Editorial: Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Prior to Liver Transplantation-Current Evidence and Future Directions.

Mohammad Saeid Rezaee-Zavareh, Ju Dong Yang

Pageof 10

Frequent Collaborators

20 joint publications

Amit G Singal

11 joint publications

Karn Wijarnpreecha

10 joint publications

Pojsakorn Danpanichkul

8 joint publications

Neehar D Parikh